| 1.2 |
3.5 |
GO:2001139 |
negative regulation of postsynaptic membrane organization(GO:1901627) negative regulation of dendritic spine maintenance(GO:1902951) negative regulation of phospholipid efflux(GO:1902999) regulation of lipid transport across blood brain barrier(GO:1903000) negative regulation of lipid transport across blood brain barrier(GO:1903001) positive regulation of lipid transport across blood brain barrier(GO:1903002) negative regulation of phospholipid transport(GO:2001139) |
| 1.0 |
3.0 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.9 |
2.6 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.8 |
3.2 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
| 0.7 |
4.4 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.7 |
0.7 |
GO:0071600 |
otic vesicle morphogenesis(GO:0071600) |
| 0.7 |
1.4 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
| 0.7 |
1.4 |
GO:0090128 |
regulation of synapse maturation(GO:0090128) |
| 0.7 |
2.0 |
GO:0007210 |
serotonin receptor signaling pathway(GO:0007210) |
| 0.7 |
1.3 |
GO:0090191 |
negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
| 0.6 |
4.4 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
| 0.6 |
1.8 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.6 |
3.6 |
GO:1903275 |
positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
| 0.6 |
4.1 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.6 |
4.1 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 0.6 |
3.5 |
GO:0060718 |
chorionic trophoblast cell differentiation(GO:0060718) |
| 0.6 |
2.9 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.6 |
1.1 |
GO:0061314 |
Notch signaling involved in heart development(GO:0061314) |
| 0.5 |
1.6 |
GO:0042939 |
glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 0.5 |
1.6 |
GO:2000983 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.5 |
0.5 |
GO:0097154 |
GABAergic neuron differentiation(GO:0097154) |
| 0.5 |
4.3 |
GO:0000050 |
urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
| 0.5 |
1.6 |
GO:0030421 |
defecation(GO:0030421) |
| 0.5 |
1.6 |
GO:0002159 |
desmosome assembly(GO:0002159) |
| 0.5 |
2.6 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.5 |
1.5 |
GO:0090194 |
negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
| 0.5 |
2.5 |
GO:0060050 |
positive regulation of protein glycosylation(GO:0060050) |
| 0.5 |
2.0 |
GO:1903587 |
regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
| 0.5 |
1.5 |
GO:0036388 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.5 |
5.4 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.5 |
1.5 |
GO:0034162 |
toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.5 |
1.9 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.5 |
1.4 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.5 |
3.2 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.5 |
1.8 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 0.5 |
1.8 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 0.5 |
0.5 |
GO:0032656 |
interleukin-13 production(GO:0032616) interleukin-5 production(GO:0032634) regulation of interleukin-13 production(GO:0032656) regulation of interleukin-5 production(GO:0032674) |
| 0.4 |
1.7 |
GO:1903800 |
positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.4 |
2.6 |
GO:0036233 |
glycine import(GO:0036233) |
| 0.4 |
2.6 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.4 |
1.3 |
GO:0003100 |
regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
| 0.4 |
3.4 |
GO:1903596 |
regulation of gap junction assembly(GO:1903596) |
| 0.4 |
0.8 |
GO:0014826 |
vein smooth muscle contraction(GO:0014826) |
| 0.4 |
8.4 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
| 0.4 |
4.3 |
GO:0071635 |
negative regulation of transforming growth factor beta production(GO:0071635) |
| 0.4 |
1.2 |
GO:1904685 |
positive regulation of metalloendopeptidase activity(GO:1904685) |
| 0.4 |
1.5 |
GO:1904451 |
regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
| 0.4 |
1.1 |
GO:0072180 |
mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) mesonephric duct development(GO:0072177) mesonephric duct morphogenesis(GO:0072180) |
| 0.4 |
1.1 |
GO:0046671 |
negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.4 |
3.3 |
GO:0060662 |
tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.4 |
1.1 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.4 |
1.4 |
GO:0036006 |
response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
| 0.3 |
2.1 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.3 |
1.0 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.3 |
1.0 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 0.3 |
0.7 |
GO:0050855 |
regulation of B cell receptor signaling pathway(GO:0050855) |
| 0.3 |
1.0 |
GO:0071260 |
cellular response to mechanical stimulus(GO:0071260) |
| 0.3 |
0.7 |
GO:0032847 |
regulation of cellular pH reduction(GO:0032847) |
| 0.3 |
1.0 |
GO:0046104 |
thymidine metabolic process(GO:0046104) |
| 0.3 |
1.3 |
GO:0032901 |
positive regulation of neurotrophin production(GO:0032901) |
| 0.3 |
0.7 |
GO:0045723 |
positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.3 |
1.0 |
GO:0006507 |
GPI anchor release(GO:0006507) |
| 0.3 |
1.0 |
GO:0021893 |
cerebral cortex GABAergic interneuron fate commitment(GO:0021893) |
| 0.3 |
1.0 |
GO:0042196 |
dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 0.3 |
1.3 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.3 |
2.3 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.3 |
1.0 |
GO:0009193 |
pyrimidine ribonucleoside diphosphate metabolic process(GO:0009193) UDP metabolic process(GO:0046048) |
| 0.3 |
1.0 |
GO:0030827 |
negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 0.3 |
0.3 |
GO:0032489 |
regulation of Cdc42 protein signal transduction(GO:0032489) |
| 0.3 |
0.9 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
| 0.3 |
1.9 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.3 |
0.9 |
GO:0002586 |
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.3 |
0.3 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 0.3 |
0.9 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.3 |
1.8 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.3 |
0.3 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.3 |
0.6 |
GO:0032804 |
negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
| 0.3 |
0.9 |
GO:0072034 |
renal vesicle induction(GO:0072034) |
| 0.3 |
1.2 |
GO:2000851 |
positive regulation of glucocorticoid secretion(GO:2000851) |
| 0.3 |
2.1 |
GO:0042590 |
antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.3 |
3.5 |
GO:0045217 |
cell-cell junction maintenance(GO:0045217) |
| 0.3 |
1.5 |
GO:2000680 |
regulation of rubidium ion transport(GO:2000680) |
| 0.3 |
0.9 |
GO:0033632 |
regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
| 0.3 |
1.2 |
GO:0021586 |
pons maturation(GO:0021586) |
| 0.3 |
0.9 |
GO:0033499 |
galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
| 0.3 |
0.9 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 0.3 |
1.7 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.3 |
0.6 |
GO:0014738 |
regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
| 0.3 |
1.1 |
GO:1901252 |
regulation of intracellular transport of viral material(GO:1901252) |
| 0.3 |
0.6 |
GO:1900426 |
positive regulation of defense response to bacterium(GO:1900426) |
| 0.3 |
0.8 |
GO:2000314 |
negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.3 |
0.6 |
GO:1902566 |
regulation of eosinophil activation(GO:1902566) |
| 0.3 |
0.8 |
GO:2000402 |
negative regulation of lymphocyte migration(GO:2000402) |
| 0.3 |
0.8 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.3 |
3.3 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.3 |
0.5 |
GO:0010533 |
regulation of activation of Janus kinase activity(GO:0010533) regulation of activation of JAK2 kinase activity(GO:0010534) |
| 0.3 |
0.8 |
GO:1901628 |
positive regulation of postsynaptic membrane organization(GO:1901628) |
| 0.3 |
2.2 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.3 |
0.8 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 0.3 |
4.0 |
GO:0021798 |
forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.3 |
1.3 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.3 |
0.8 |
GO:0002606 |
positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
| 0.3 |
0.8 |
GO:0007172 |
signal complex assembly(GO:0007172) |
| 0.3 |
0.8 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.3 |
0.3 |
GO:0060648 |
mammary gland bud morphogenesis(GO:0060648) |
| 0.3 |
2.9 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.3 |
2.3 |
GO:0021892 |
cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
| 0.3 |
1.3 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.3 |
0.3 |
GO:0044333 |
Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 0.3 |
2.3 |
GO:0060872 |
semicircular canal morphogenesis(GO:0048752) semicircular canal development(GO:0060872) |
| 0.2 |
0.7 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.2 |
1.7 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.2 |
0.7 |
GO:0010636 |
positive regulation of mitochondrial fusion(GO:0010636) |
| 0.2 |
1.2 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.2 |
0.5 |
GO:2000043 |
regulation of cardiac cell fate specification(GO:2000043) |
| 0.2 |
0.2 |
GO:0051542 |
elastin biosynthetic process(GO:0051542) |
| 0.2 |
0.5 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.2 |
1.4 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 0.2 |
3.4 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.2 |
1.6 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.2 |
0.5 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.2 |
1.6 |
GO:0015670 |
carbon dioxide transport(GO:0015670) |
| 0.2 |
1.3 |
GO:0043415 |
positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 0.2 |
0.9 |
GO:0071449 |
cellular response to lipid hydroperoxide(GO:0071449) |
| 0.2 |
0.6 |
GO:0043465 |
regulation of fermentation(GO:0043465) negative regulation of fermentation(GO:1901003) |
| 0.2 |
0.2 |
GO:0032902 |
nerve growth factor production(GO:0032902) |
| 0.2 |
1.1 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.2 |
1.9 |
GO:0015868 |
purine ribonucleotide transport(GO:0015868) |
| 0.2 |
0.4 |
GO:0036292 |
DNA rewinding(GO:0036292) |
| 0.2 |
1.0 |
GO:2000325 |
regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.2 |
1.2 |
GO:0042742 |
defense response to bacterium(GO:0042742) |
| 0.2 |
1.0 |
GO:0032346 |
positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
| 0.2 |
1.8 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.2 |
0.6 |
GO:1900039 |
positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.2 |
1.8 |
GO:0097070 |
ductus arteriosus closure(GO:0097070) |
| 0.2 |
0.8 |
GO:2000525 |
regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 0.2 |
0.6 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.2 |
0.6 |
GO:0061743 |
motor learning(GO:0061743) |
| 0.2 |
0.4 |
GO:0033278 |
cell proliferation in midbrain(GO:0033278) |
| 0.2 |
1.4 |
GO:2001185 |
regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
| 0.2 |
0.6 |
GO:0035106 |
operant conditioning(GO:0035106) |
| 0.2 |
0.6 |
GO:0003223 |
ventricular compact myocardium morphogenesis(GO:0003223) |
| 0.2 |
0.8 |
GO:0016114 |
terpenoid biosynthetic process(GO:0016114) |
| 0.2 |
0.6 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
| 0.2 |
0.2 |
GO:0060316 |
positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.2 |
0.6 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.2 |
1.7 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.2 |
0.6 |
GO:0034035 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
| 0.2 |
0.9 |
GO:0043129 |
surfactant homeostasis(GO:0043129) |
| 0.2 |
0.9 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.2 |
0.7 |
GO:0010387 |
COP9 signalosome assembly(GO:0010387) |
| 0.2 |
0.9 |
GO:0051365 |
cellular response to potassium ion starvation(GO:0051365) |
| 0.2 |
2.4 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.2 |
1.1 |
GO:0048711 |
positive regulation of astrocyte differentiation(GO:0048711) |
| 0.2 |
0.4 |
GO:0036518 |
chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.2 |
1.3 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.2 |
0.9 |
GO:0038166 |
angiotensin-activated signaling pathway(GO:0038166) |
| 0.2 |
0.5 |
GO:0010455 |
positive regulation of cell fate commitment(GO:0010455) |
| 0.2 |
1.1 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.2 |
1.1 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.2 |
0.5 |
GO:0042822 |
vitamin B6 metabolic process(GO:0042816) pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.2 |
0.7 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.2 |
0.2 |
GO:0032803 |
low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
| 0.2 |
1.2 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.2 |
0.7 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.2 |
0.5 |
GO:0010896 |
regulation of triglyceride catabolic process(GO:0010896) positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.2 |
0.3 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.2 |
0.2 |
GO:1900242 |
regulation of synaptic vesicle endocytosis(GO:1900242) |
| 0.2 |
2.5 |
GO:0045987 |
positive regulation of smooth muscle contraction(GO:0045987) |
| 0.2 |
0.5 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.2 |
0.5 |
GO:0043696 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.2 |
0.2 |
GO:1990314 |
cellular response to insulin-like growth factor stimulus(GO:1990314) |
| 0.2 |
0.2 |
GO:0002678 |
positive regulation of chronic inflammatory response(GO:0002678) |
| 0.2 |
1.0 |
GO:0071455 |
cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
| 0.2 |
0.2 |
GO:0071726 |
response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
| 0.2 |
0.3 |
GO:0035990 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.2 |
0.3 |
GO:0007262 |
STAT protein import into nucleus(GO:0007262) |
| 0.2 |
2.7 |
GO:0035994 |
response to muscle stretch(GO:0035994) |
| 0.2 |
1.1 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.2 |
0.8 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 0.2 |
0.2 |
GO:0060423 |
foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
| 0.2 |
0.3 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
| 0.2 |
0.8 |
GO:0035166 |
post-embryonic hemopoiesis(GO:0035166) |
| 0.2 |
0.5 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.2 |
1.1 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.2 |
0.5 |
GO:0014819 |
regulation of skeletal muscle contraction(GO:0014819) |
| 0.2 |
0.2 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.2 |
0.8 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.2 |
0.8 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
| 0.2 |
0.8 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.2 |
0.2 |
GO:2000313 |
fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
| 0.2 |
2.9 |
GO:0007614 |
short-term memory(GO:0007614) |
| 0.2 |
0.8 |
GO:0014842 |
regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
| 0.2 |
0.2 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) |
| 0.2 |
0.5 |
GO:1902310 |
positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.2 |
0.5 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.2 |
1.1 |
GO:0036159 |
inner dynein arm assembly(GO:0036159) |
| 0.1 |
1.6 |
GO:2000653 |
regulation of genetic imprinting(GO:2000653) |
| 0.1 |
0.6 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.1 |
0.7 |
GO:0002677 |
negative regulation of chronic inflammatory response(GO:0002677) |
| 0.1 |
0.7 |
GO:0006167 |
AMP biosynthetic process(GO:0006167) |
| 0.1 |
0.3 |
GO:0060510 |
Type II pneumocyte differentiation(GO:0060510) |
| 0.1 |
1.6 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.1 |
0.1 |
GO:1901630 |
negative regulation of presynaptic membrane organization(GO:1901630) |
| 0.1 |
2.2 |
GO:0009109 |
coenzyme catabolic process(GO:0009109) |
| 0.1 |
1.2 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.1 |
0.6 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 0.1 |
0.1 |
GO:0048853 |
forebrain morphogenesis(GO:0048853) |
| 0.1 |
0.7 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 |
0.1 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.1 |
2.1 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 0.1 |
0.8 |
GO:0044027 |
hypermethylation of CpG island(GO:0044027) |
| 0.1 |
0.1 |
GO:1903207 |
neuron death in response to hydrogen peroxide(GO:0036476) neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) |
| 0.1 |
0.3 |
GO:0002467 |
germinal center formation(GO:0002467) |
| 0.1 |
1.5 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.1 |
0.6 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
| 0.1 |
0.8 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.1 |
0.7 |
GO:1903861 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.1 |
0.1 |
GO:0021562 |
vestibulocochlear nerve development(GO:0021562) |
| 0.1 |
1.2 |
GO:0045056 |
transcytosis(GO:0045056) |
| 0.1 |
1.8 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 |
0.5 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.1 |
0.8 |
GO:0002043 |
blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.1 |
0.3 |
GO:0030538 |
embryonic genitalia morphogenesis(GO:0030538) |
| 0.1 |
0.4 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.1 |
0.5 |
GO:0043383 |
negative T cell selection(GO:0043383) negative thymic T cell selection(GO:0045060) |
| 0.1 |
0.1 |
GO:0061043 |
regulation of vascular wound healing(GO:0061043) |
| 0.1 |
3.6 |
GO:0009648 |
photoperiodism(GO:0009648) |
| 0.1 |
0.9 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.1 |
0.8 |
GO:1901534 |
positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
| 0.1 |
0.3 |
GO:0043096 |
purine nucleobase salvage(GO:0043096) |
| 0.1 |
0.8 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.1 |
0.4 |
GO:1902358 |
sulfate transmembrane transport(GO:1902358) |
| 0.1 |
1.4 |
GO:2000831 |
regulation of steroid hormone secretion(GO:2000831) |
| 0.1 |
0.4 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.1 |
0.3 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.1 |
1.3 |
GO:0007096 |
regulation of exit from mitosis(GO:0007096) |
| 0.1 |
0.8 |
GO:0051987 |
positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
| 0.1 |
0.4 |
GO:0034392 |
negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
| 0.1 |
0.5 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.1 |
0.6 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.1 |
0.5 |
GO:0006842 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.1 |
0.4 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.1 |
0.3 |
GO:2000668 |
dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
| 0.1 |
1.0 |
GO:2000010 |
positive regulation of protein localization to cell surface(GO:2000010) |
| 0.1 |
0.8 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.1 |
0.1 |
GO:0061141 |
lung ciliated cell differentiation(GO:0061141) |
| 0.1 |
0.2 |
GO:0010511 |
regulation of phosphatidylinositol biosynthetic process(GO:0010511) negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.1 |
0.7 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.1 |
0.1 |
GO:0010954 |
positive regulation of protein processing(GO:0010954) positive regulation of protein maturation(GO:1903319) |
| 0.1 |
0.4 |
GO:0019343 |
cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
| 0.1 |
0.5 |
GO:0015819 |
lysine transport(GO:0015819) |
| 0.1 |
0.4 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.1 |
0.8 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.1 |
0.7 |
GO:0098700 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.1 |
0.7 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.1 |
0.6 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.1 |
0.2 |
GO:0032488 |
Cdc42 protein signal transduction(GO:0032488) |
| 0.1 |
0.7 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.1 |
0.6 |
GO:0010820 |
positive regulation of T cell chemotaxis(GO:0010820) |
| 0.1 |
0.4 |
GO:0001951 |
intestinal D-glucose absorption(GO:0001951) terminal web assembly(GO:1902896) |
| 0.1 |
0.2 |
GO:0060437 |
lung growth(GO:0060437) |
| 0.1 |
0.3 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.1 |
0.5 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.1 |
0.6 |
GO:0032423 |
regulation of mismatch repair(GO:0032423) |
| 0.1 |
0.3 |
GO:0006590 |
thyroid hormone generation(GO:0006590) |
| 0.1 |
0.1 |
GO:0009786 |
regulation of asymmetric cell division(GO:0009786) |
| 0.1 |
0.8 |
GO:1903423 |
positive regulation of synaptic vesicle recycling(GO:1903423) |
| 0.1 |
0.3 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.1 |
0.5 |
GO:0048245 |
eosinophil chemotaxis(GO:0048245) |
| 0.1 |
1.5 |
GO:0034383 |
low-density lipoprotein particle clearance(GO:0034383) |
| 0.1 |
0.1 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.1 |
0.1 |
GO:0001844 |
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
| 0.1 |
0.1 |
GO:0046544 |
development of secondary male sexual characteristics(GO:0046544) |
| 0.1 |
0.6 |
GO:1901341 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.1 |
2.5 |
GO:2000249 |
regulation of actin cytoskeleton reorganization(GO:2000249) |
| 0.1 |
0.1 |
GO:0048550 |
negative regulation of pinocytosis(GO:0048550) |
| 0.1 |
0.1 |
GO:0034776 |
response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
| 0.1 |
0.3 |
GO:0051342 |
regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.1 |
0.6 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.1 |
0.1 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.1 |
0.2 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.1 |
0.2 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) |
| 0.1 |
0.1 |
GO:0042045 |
epithelial fluid transport(GO:0042045) |
| 0.1 |
1.8 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 0.1 |
0.3 |
GO:0003057 |
regulation of the force of heart contraction by chemical signal(GO:0003057) |
| 0.1 |
0.1 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
| 0.1 |
0.5 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.1 |
0.5 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
| 0.1 |
0.2 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.1 |
0.2 |
GO:0003180 |
aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
| 0.1 |
0.7 |
GO:0019254 |
carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.1 |
0.3 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.1 |
0.4 |
GO:0010273 |
detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 0.1 |
1.2 |
GO:0002504 |
antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
| 0.1 |
0.8 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.1 |
1.0 |
GO:0060445 |
branching involved in salivary gland morphogenesis(GO:0060445) |
| 0.1 |
0.5 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.1 |
0.7 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.1 |
1.4 |
GO:0071624 |
positive regulation of granulocyte chemotaxis(GO:0071624) positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.1 |
0.4 |
GO:0071104 |
response to interleukin-9(GO:0071104) |
| 0.1 |
0.2 |
GO:0045657 |
positive regulation of monocyte differentiation(GO:0045657) |
| 0.1 |
0.1 |
GO:2001268 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.1 |
0.5 |
GO:0032796 |
uropod organization(GO:0032796) |
| 0.1 |
0.3 |
GO:1903026 |
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.1 |
1.9 |
GO:0043217 |
myelin maintenance(GO:0043217) |
| 0.1 |
2.2 |
GO:0050853 |
B cell receptor signaling pathway(GO:0050853) |
| 0.1 |
0.2 |
GO:0001306 |
age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
| 0.1 |
0.1 |
GO:0045925 |
positive regulation of female receptivity(GO:0045925) |
| 0.1 |
0.4 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.1 |
0.9 |
GO:0072010 |
renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
| 0.1 |
0.1 |
GO:1900451 |
positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.1 |
1.4 |
GO:0039702 |
viral budding via host ESCRT complex(GO:0039702) |
| 0.1 |
0.3 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.1 |
0.5 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.1 |
0.1 |
GO:0007521 |
muscle cell fate determination(GO:0007521) |
| 0.1 |
0.3 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.1 |
0.2 |
GO:0002339 |
B cell selection(GO:0002339) B cell negative selection(GO:0002352) establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.1 |
0.1 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 0.1 |
0.1 |
GO:0018197 |
peptidyl-aspartic acid modification(GO:0018197) |
| 0.1 |
2.0 |
GO:0010866 |
regulation of triglyceride biosynthetic process(GO:0010866) |
| 0.1 |
1.0 |
GO:0032463 |
negative regulation of protein homooligomerization(GO:0032463) |
| 0.1 |
0.5 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.1 |
0.5 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.1 |
0.5 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.1 |
0.3 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.1 |
0.8 |
GO:0032757 |
positive regulation of interleukin-8 production(GO:0032757) |
| 0.1 |
0.3 |
GO:0006702 |
androgen biosynthetic process(GO:0006702) |
| 0.1 |
0.4 |
GO:0002634 |
regulation of germinal center formation(GO:0002634) |
| 0.1 |
0.4 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 0.1 |
0.5 |
GO:0070460 |
thyroid-stimulating hormone secretion(GO:0070460) |
| 0.1 |
3.4 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
| 0.1 |
0.6 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.1 |
3.2 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.1 |
0.8 |
GO:0033689 |
negative regulation of osteoblast proliferation(GO:0033689) |
| 0.1 |
0.4 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.1 |
0.1 |
GO:0042795 |
snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.1 |
0.8 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.1 |
0.4 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 |
0.6 |
GO:0044130 |
negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
| 0.1 |
0.4 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.1 |
0.3 |
GO:0032687 |
negative regulation of interferon-alpha production(GO:0032687) |
| 0.1 |
0.6 |
GO:0001516 |
prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
| 0.1 |
0.1 |
GO:1900107 |
regulation of nodal signaling pathway(GO:1900107) |
| 0.1 |
0.3 |
GO:0090037 |
positive regulation of protein kinase C signaling(GO:0090037) |
| 0.1 |
1.0 |
GO:0009438 |
methylglyoxal metabolic process(GO:0009438) |
| 0.1 |
0.4 |
GO:0070813 |
hydrogen sulfide metabolic process(GO:0070813) |
| 0.1 |
0.3 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.1 |
1.6 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.1 |
0.1 |
GO:0043585 |
nose morphogenesis(GO:0043585) |
| 0.1 |
0.3 |
GO:2000645 |
negative regulation of receptor catabolic process(GO:2000645) |
| 0.1 |
1.0 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 0.1 |
0.1 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 0.1 |
0.3 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.1 |
0.5 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.1 |
2.3 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.1 |
0.5 |
GO:0061029 |
eyelid development in camera-type eye(GO:0061029) |
| 0.1 |
0.3 |
GO:0051126 |
negative regulation of actin nucleation(GO:0051126) |
| 0.1 |
0.7 |
GO:0006450 |
regulation of translational fidelity(GO:0006450) |
| 0.1 |
0.2 |
GO:0019478 |
D-amino acid catabolic process(GO:0019478) |
| 0.1 |
1.0 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.1 |
0.2 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.1 |
0.4 |
GO:0002726 |
positive regulation of T cell cytokine production(GO:0002726) |
| 0.1 |
0.2 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.1 |
0.5 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.1 |
0.9 |
GO:0032516 |
positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
| 0.1 |
1.6 |
GO:0001913 |
T cell mediated cytotoxicity(GO:0001913) |
| 0.1 |
0.7 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.1 |
0.7 |
GO:0097421 |
liver regeneration(GO:0097421) |
| 0.1 |
0.8 |
GO:0032703 |
negative regulation of interleukin-2 production(GO:0032703) |
| 0.1 |
0.1 |
GO:2000823 |
regulation of androgen receptor activity(GO:2000823) |
| 0.1 |
0.9 |
GO:0021859 |
pyramidal neuron differentiation(GO:0021859) |
| 0.1 |
0.5 |
GO:0031639 |
plasminogen activation(GO:0031639) |
| 0.1 |
0.2 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 0.1 |
0.2 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.1 |
0.2 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 0.1 |
0.8 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.1 |
0.8 |
GO:2000060 |
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.1 |
1.0 |
GO:0010831 |
positive regulation of myotube differentiation(GO:0010831) |
| 0.1 |
0.2 |
GO:2000780 |
negative regulation of DNA repair(GO:0045738) negative regulation of double-strand break repair(GO:2000780) |
| 0.1 |
0.2 |
GO:0050847 |
progesterone receptor signaling pathway(GO:0050847) |
| 0.1 |
0.1 |
GO:0031120 |
snRNA pseudouridine synthesis(GO:0031120) |
| 0.1 |
0.2 |
GO:1903011 |
negative regulation of bone development(GO:1903011) |
| 0.1 |
0.2 |
GO:0098528 |
skeletal muscle fiber differentiation(GO:0098528) |
| 0.1 |
0.5 |
GO:0071850 |
mitotic cell cycle arrest(GO:0071850) |
| 0.1 |
1.3 |
GO:0001504 |
neurotransmitter uptake(GO:0001504) |
| 0.1 |
0.1 |
GO:1900424 |
regulation of defense response to bacterium(GO:1900424) |
| 0.1 |
0.1 |
GO:0009649 |
entrainment of circadian clock(GO:0009649) |
| 0.1 |
0.1 |
GO:2001286 |
regulation of caveolin-mediated endocytosis(GO:2001286) |
| 0.1 |
0.2 |
GO:0009414 |
response to water deprivation(GO:0009414) |
| 0.1 |
0.3 |
GO:0071468 |
cellular response to acidic pH(GO:0071468) |
| 0.1 |
0.2 |
GO:1902202 |
regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.1 |
0.7 |
GO:0033327 |
Leydig cell differentiation(GO:0033327) |
| 0.1 |
0.2 |
GO:1903352 |
ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
| 0.1 |
0.2 |
GO:0070589 |
cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
| 0.1 |
0.1 |
GO:0032310 |
prostaglandin transport(GO:0015732) prostaglandin secretion(GO:0032310) |
| 0.1 |
0.2 |
GO:0035928 |
rRNA import into mitochondrion(GO:0035928) |
| 0.1 |
0.4 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.1 |
0.3 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.1 |
0.2 |
GO:0034287 |
detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.1 |
0.1 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.1 |
0.6 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.1 |
0.3 |
GO:0070102 |
interleukin-6-mediated signaling pathway(GO:0070102) |
| 0.1 |
0.3 |
GO:0090336 |
positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.1 |
2.1 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.1 |
0.5 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.1 |
0.1 |
GO:0072071 |
mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) pericyte cell differentiation(GO:1904238) |
| 0.1 |
0.1 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 0.1 |
0.3 |
GO:1902224 |
cellular ketone body metabolic process(GO:0046950) ketone body metabolic process(GO:1902224) |
| 0.1 |
0.6 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.1 |
1.0 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.1 |
0.9 |
GO:0045475 |
locomotor rhythm(GO:0045475) |
| 0.1 |
0.3 |
GO:0046456 |
icosanoid biosynthetic process(GO:0046456) fatty acid derivative biosynthetic process(GO:1901570) |
| 0.1 |
0.1 |
GO:0010749 |
regulation of nitric oxide mediated signal transduction(GO:0010749) |
| 0.1 |
0.2 |
GO:0002921 |
negative regulation of humoral immune response(GO:0002921) |
| 0.1 |
0.4 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.1 |
0.3 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.1 |
0.1 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.1 |
0.5 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.1 |
0.9 |
GO:0031065 |
positive regulation of histone deacetylation(GO:0031065) |
| 0.1 |
0.2 |
GO:0071873 |
response to norepinephrine(GO:0071873) |
| 0.1 |
0.2 |
GO:2000619 |
negative regulation of histone H4-K16 acetylation(GO:2000619) |
| 0.1 |
0.1 |
GO:0060405 |
regulation of penile erection(GO:0060405) positive regulation of penile erection(GO:0060406) |
| 0.1 |
0.4 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.1 |
1.0 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.1 |
0.2 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.1 |
0.1 |
GO:0035552 |
oxidative single-stranded DNA demethylation(GO:0035552) |
| 0.1 |
1.3 |
GO:1900153 |
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.1 |
0.3 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 |
0.4 |
GO:0043137 |
DNA replication, removal of RNA primer(GO:0043137) |
| 0.1 |
0.2 |
GO:0010936 |
negative regulation of cytokine production involved in immune response(GO:0002719) negative regulation of macrophage cytokine production(GO:0010936) |
| 0.1 |
0.2 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.1 |
0.3 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.1 |
0.4 |
GO:0032261 |
purine nucleotide salvage(GO:0032261) |
| 0.1 |
0.1 |
GO:0042699 |
follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.1 |
0.2 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.1 |
0.1 |
GO:0045342 |
MHC class II biosynthetic process(GO:0045342) |
| 0.1 |
0.1 |
GO:0060467 |
negative regulation of fertilization(GO:0060467) |
| 0.1 |
2.3 |
GO:0030835 |
negative regulation of actin filament depolymerization(GO:0030835) |
| 0.1 |
0.4 |
GO:0070207 |
protein homotrimerization(GO:0070207) |
| 0.1 |
1.2 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.1 |
0.1 |
GO:0048859 |
formation of anatomical boundary(GO:0048859) |
| 0.1 |
0.4 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.1 |
0.2 |
GO:0007039 |
protein catabolic process in the vacuole(GO:0007039) |
| 0.1 |
0.2 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 |
0.2 |
GO:0046013 |
T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.1 |
1.5 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.1 |
0.3 |
GO:0032292 |
myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.1 |
0.1 |
GO:0035633 |
maintenance of blood-brain barrier(GO:0035633) |
| 0.1 |
2.1 |
GO:0071277 |
cellular response to calcium ion(GO:0071277) |
| 0.1 |
0.1 |
GO:0006207 |
'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.1 |
0.2 |
GO:0033603 |
positive regulation of dopamine secretion(GO:0033603) |
| 0.1 |
0.1 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.1 |
0.2 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.1 |
0.2 |
GO:0046210 |
nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.1 |
0.2 |
GO:0009415 |
response to water(GO:0009415) |
| 0.1 |
0.6 |
GO:0046500 |
S-adenosylmethionine metabolic process(GO:0046500) |
| 0.1 |
0.2 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.1 |
0.9 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.1 |
0.1 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.1 |
0.6 |
GO:0046051 |
UTP metabolic process(GO:0046051) |
| 0.1 |
0.3 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 0.1 |
0.6 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.1 |
0.3 |
GO:0016560 |
protein import into peroxisome matrix, docking(GO:0016560) |
| 0.1 |
0.1 |
GO:0060221 |
retinal rod cell differentiation(GO:0060221) |
| 0.1 |
0.8 |
GO:0044243 |
collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
| 0.1 |
0.3 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.1 |
0.1 |
GO:0045687 |
positive regulation of glial cell differentiation(GO:0045687) |
| 0.1 |
0.6 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.1 |
0.2 |
GO:0046135 |
pyrimidine ribonucleoside catabolic process(GO:0046133) pyrimidine nucleoside catabolic process(GO:0046135) |
| 0.1 |
0.4 |
GO:0070458 |
detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.1 |
0.6 |
GO:0010388 |
protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
| 0.1 |
0.1 |
GO:1901655 |
cellular response to ketone(GO:1901655) |
| 0.1 |
0.5 |
GO:2000191 |
regulation of fatty acid transport(GO:2000191) |
| 0.1 |
0.2 |
GO:1902166 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
| 0.1 |
0.2 |
GO:0042415 |
norepinephrine metabolic process(GO:0042415) |
| 0.1 |
0.7 |
GO:0032785 |
negative regulation of DNA-templated transcription, elongation(GO:0032785) |
| 0.1 |
0.2 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.1 |
0.5 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.1 |
0.7 |
GO:0008625 |
extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
| 0.1 |
0.1 |
GO:0035511 |
oxidative DNA demethylation(GO:0035511) |
| 0.1 |
0.2 |
GO:1904879 |
positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.1 |
0.1 |
GO:0048670 |
regulation of collateral sprouting(GO:0048670) |
| 0.1 |
2.6 |
GO:0019882 |
antigen processing and presentation(GO:0019882) |
| 0.1 |
0.1 |
GO:0060334 |
regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.1 |
0.3 |
GO:0051103 |
DNA ligation involved in DNA repair(GO:0051103) |
| 0.1 |
0.3 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.1 |
0.2 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.1 |
0.6 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.1 |
0.3 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.1 |
0.2 |
GO:0021979 |
hypothalamus cell differentiation(GO:0021979) |
| 0.1 |
0.4 |
GO:0042659 |
regulation of cell fate specification(GO:0042659) |
| 0.1 |
0.2 |
GO:0001831 |
trophectodermal cellular morphogenesis(GO:0001831) |
| 0.1 |
0.8 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.1 |
0.4 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.1 |
0.1 |
GO:0019433 |
triglyceride catabolic process(GO:0019433) |
| 0.1 |
0.7 |
GO:0010039 |
response to iron ion(GO:0010039) |
| 0.1 |
0.1 |
GO:0061042 |
vascular wound healing(GO:0061042) |
| 0.0 |
0.1 |
GO:0006285 |
base-excision repair, AP site formation(GO:0006285) |
| 0.0 |
0.1 |
GO:2001267 |
regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) |
| 0.0 |
0.0 |
GO:0070257 |
positive regulation of mucus secretion(GO:0070257) |
| 0.0 |
0.1 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.0 |
0.2 |
GO:0007398 |
ectoderm development(GO:0007398) |
| 0.0 |
0.2 |
GO:0070092 |
glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
| 0.0 |
0.1 |
GO:0051182 |
coenzyme transport(GO:0051182) |
| 0.0 |
0.2 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.0 |
0.6 |
GO:0003009 |
skeletal muscle contraction(GO:0003009) |
| 0.0 |
0.2 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
| 0.0 |
0.1 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.0 |
0.1 |
GO:0061436 |
establishment of skin barrier(GO:0061436) |
| 0.0 |
0.3 |
GO:0071800 |
podosome assembly(GO:0071800) |
| 0.0 |
0.2 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.0 |
0.1 |
GO:0061014 |
positive regulation of mRNA catabolic process(GO:0061014) |
| 0.0 |
0.4 |
GO:0006560 |
proline metabolic process(GO:0006560) |
| 0.0 |
0.2 |
GO:0046684 |
response to pyrethroid(GO:0046684) |
| 0.0 |
0.1 |
GO:0035356 |
cellular triglyceride homeostasis(GO:0035356) |
| 0.0 |
0.1 |
GO:2000152 |
regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) regulation of ubiquitin-specific protease activity(GO:2000152) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.0 |
0.9 |
GO:0032981 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.0 |
0.3 |
GO:0098838 |
reduced folate transmembrane transport(GO:0098838) |
| 0.0 |
0.2 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.0 |
0.4 |
GO:0043206 |
extracellular fibril organization(GO:0043206) |
| 0.0 |
0.3 |
GO:0070741 |
response to interleukin-6(GO:0070741) |
| 0.0 |
0.0 |
GO:0006531 |
aspartate metabolic process(GO:0006531) |
| 0.0 |
0.1 |
GO:0034123 |
positive regulation of toll-like receptor signaling pathway(GO:0034123) |
| 0.0 |
0.3 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.0 |
0.2 |
GO:0071467 |
cellular response to pH(GO:0071467) |
| 0.0 |
0.0 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.0 |
0.2 |
GO:0097211 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.0 |
0.4 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.0 |
0.1 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.0 |
0.0 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 0.0 |
0.8 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.0 |
0.3 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.0 |
0.2 |
GO:0001302 |
replicative cell aging(GO:0001302) |
| 0.0 |
0.0 |
GO:0090494 |
catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 0.0 |
0.1 |
GO:0051769 |
nitric-oxide synthase biosynthetic process(GO:0051767) regulation of nitric-oxide synthase biosynthetic process(GO:0051769) positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
| 0.0 |
0.4 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.0 |
0.9 |
GO:0046677 |
response to antibiotic(GO:0046677) |
| 0.0 |
0.8 |
GO:0050779 |
RNA destabilization(GO:0050779) |
| 0.0 |
0.4 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.0 |
0.1 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.0 |
0.3 |
GO:0050858 |
negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
| 0.0 |
1.2 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.0 |
0.1 |
GO:0061052 |
negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
| 0.0 |
0.2 |
GO:2001054 |
negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
| 0.0 |
0.2 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.0 |
0.6 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.0 |
0.2 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.0 |
0.7 |
GO:0006744 |
ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.0 |
0.7 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 0.0 |
0.1 |
GO:1902044 |
regulation of Fas signaling pathway(GO:1902044) negative regulation of Fas signaling pathway(GO:1902045) |
| 0.0 |
0.1 |
GO:0046880 |
regulation of follicle-stimulating hormone secretion(GO:0046880) follicle-stimulating hormone secretion(GO:0046884) |
| 0.0 |
0.1 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 0.0 |
0.4 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.0 |
0.6 |
GO:0043496 |
regulation of protein homodimerization activity(GO:0043496) |
| 0.0 |
0.2 |
GO:0006693 |
prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 0.0 |
0.1 |
GO:0090170 |
regulation of Golgi inheritance(GO:0090170) |
| 0.0 |
0.4 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.0 |
0.1 |
GO:0071544 |
diphosphoinositol polyphosphate metabolic process(GO:0071543) diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 0.0 |
0.3 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.0 |
0.2 |
GO:0010359 |
regulation of anion channel activity(GO:0010359) |
| 0.0 |
0.2 |
GO:0008655 |
pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 0.0 |
0.3 |
GO:0009437 |
amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
| 0.0 |
1.5 |
GO:2001238 |
positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.0 |
0.1 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.0 |
0.2 |
GO:0014889 |
muscle atrophy(GO:0014889) |
| 0.0 |
0.0 |
GO:1902804 |
negative regulation of synaptic vesicle transport(GO:1902804) |
| 0.0 |
0.2 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.0 |
0.2 |
GO:2000465 |
regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.0 |
0.5 |
GO:0034315 |
regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.0 |
0.0 |
GO:0061009 |
common bile duct development(GO:0061009) |
| 0.0 |
0.1 |
GO:0046078 |
dUMP metabolic process(GO:0046078) |
| 0.0 |
0.3 |
GO:0072520 |
seminiferous tubule development(GO:0072520) |
| 0.0 |
0.2 |
GO:0097116 |
gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 0.0 |
0.1 |
GO:2000383 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 0.0 |
0.8 |
GO:0070206 |
protein trimerization(GO:0070206) |
| 0.0 |
0.1 |
GO:0035092 |
sperm chromatin condensation(GO:0035092) |
| 0.0 |
1.1 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.0 |
0.2 |
GO:0021794 |
thalamus development(GO:0021794) |
| 0.0 |
0.1 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.0 |
1.5 |
GO:0007229 |
integrin-mediated signaling pathway(GO:0007229) |
| 0.0 |
0.1 |
GO:0010635 |
regulation of mitochondrial fusion(GO:0010635) |
| 0.0 |
0.1 |
GO:0006833 |
water transport(GO:0006833) |
| 0.0 |
0.2 |
GO:0014898 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.0 |
0.4 |
GO:0072575 |
hepatocyte proliferation(GO:0072574) epithelial cell proliferation involved in liver morphogenesis(GO:0072575) |
| 0.0 |
0.1 |
GO:0007413 |
axonal fasciculation(GO:0007413) |
| 0.0 |
0.1 |
GO:0072697 |
protein localization to cell cortex(GO:0072697) |
| 0.0 |
0.1 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.0 |
0.3 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.0 |
0.1 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.0 |
0.1 |
GO:0034184 |
positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.0 |
0.1 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 0.0 |
0.1 |
GO:0046470 |
phosphatidylcholine metabolic process(GO:0046470) |
| 0.0 |
0.1 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.0 |
0.3 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.0 |
0.2 |
GO:0015808 |
L-alanine transport(GO:0015808) |
| 0.0 |
0.2 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.0 |
0.0 |
GO:0045176 |
apical protein localization(GO:0045176) |
| 0.0 |
0.1 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.0 |
0.2 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.0 |
0.3 |
GO:0002052 |
positive regulation of neuroblast proliferation(GO:0002052) |
| 0.0 |
0.1 |
GO:0047484 |
regulation of response to osmotic stress(GO:0047484) |
| 0.0 |
0.3 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.0 |
0.0 |
GO:1900120 |
regulation of receptor binding(GO:1900120) |
| 0.0 |
0.1 |
GO:1902042 |
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
| 0.0 |
0.1 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.0 |
0.9 |
GO:0032456 |
endocytic recycling(GO:0032456) |
| 0.0 |
0.3 |
GO:0048671 |
negative regulation of collateral sprouting(GO:0048671) |
| 0.0 |
1.0 |
GO:0034724 |
DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
| 0.0 |
0.1 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.0 |
0.2 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.0 |
0.0 |
GO:0072643 |
interferon-gamma secretion(GO:0072643) |
| 0.0 |
0.7 |
GO:0071384 |
cellular response to corticosteroid stimulus(GO:0071384) cellular response to glucocorticoid stimulus(GO:0071385) |
| 0.0 |
0.1 |
GO:1902990 |
telomere maintenance via semi-conservative replication(GO:0032201) mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
| 0.0 |
0.2 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.0 |
0.1 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.0 |
0.1 |
GO:0019530 |
taurine metabolic process(GO:0019530) |
| 0.0 |
0.2 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 0.0 |
0.1 |
GO:0033128 |
negative regulation of histone phosphorylation(GO:0033128) |
| 0.0 |
0.1 |
GO:0032933 |
response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.0 |
0.1 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.0 |
0.8 |
GO:0001573 |
ganglioside metabolic process(GO:0001573) |
| 0.0 |
0.3 |
GO:0071257 |
cellular response to electrical stimulus(GO:0071257) |
| 0.0 |
0.1 |
GO:0042346 |
positive regulation of NF-kappaB import into nucleus(GO:0042346) |
| 0.0 |
0.1 |
GO:0007128 |
meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
| 0.0 |
0.2 |
GO:0045002 |
double-strand break repair via single-strand annealing(GO:0045002) |
| 0.0 |
0.1 |
GO:0010574 |
regulation of vascular endothelial growth factor production(GO:0010574) |
| 0.0 |
0.2 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.0 |
1.4 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.0 |
0.2 |
GO:0048199 |
vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.0 |
0.4 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.0 |
0.2 |
GO:0071474 |
cellular hyperosmotic response(GO:0071474) |
| 0.0 |
0.1 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.0 |
0.1 |
GO:0045852 |
lysosomal lumen pH elevation(GO:0035752) pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
| 0.0 |
0.0 |
GO:1901838 |
positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.0 |
0.1 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.0 |
0.1 |
GO:0071139 |
resolution of recombination intermediates(GO:0071139) |
| 0.0 |
0.0 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 0.0 |
0.2 |
GO:0010528 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.0 |
0.4 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.0 |
1.0 |
GO:0006635 |
fatty acid beta-oxidation(GO:0006635) |
| 0.0 |
0.2 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.0 |
0.1 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 0.0 |
0.1 |
GO:0030890 |
positive regulation of B cell proliferation(GO:0030890) |
| 0.0 |
0.1 |
GO:0034766 |
negative regulation of ion transmembrane transport(GO:0034766) |
| 0.0 |
0.2 |
GO:1904816 |
regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
| 0.0 |
0.2 |
GO:0019755 |
one-carbon compound transport(GO:0019755) |
| 0.0 |
0.1 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
| 0.0 |
0.1 |
GO:0001880 |
Mullerian duct regression(GO:0001880) |
| 0.0 |
0.2 |
GO:2000404 |
regulation of T cell migration(GO:2000404) |
| 0.0 |
0.3 |
GO:0042832 |
defense response to protozoan(GO:0042832) |
| 0.0 |
0.1 |
GO:0006451 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 |
0.0 |
GO:0032309 |
icosanoid secretion(GO:0032309) icosanoid transport(GO:0071715) fatty acid derivative transport(GO:1901571) |
| 0.0 |
0.1 |
GO:0006048 |
UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.0 |
0.1 |
GO:0051255 |
spindle midzone assembly(GO:0051255) |
| 0.0 |
0.2 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.0 |
0.1 |
GO:0009068 |
aspartate family amino acid catabolic process(GO:0009068) |
| 0.0 |
0.7 |
GO:0043489 |
RNA stabilization(GO:0043489) |
| 0.0 |
0.9 |
GO:0032091 |
negative regulation of protein binding(GO:0032091) |
| 0.0 |
0.2 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.0 |
0.3 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.0 |
0.2 |
GO:0046602 |
regulation of mitotic centrosome separation(GO:0046602) |
| 0.0 |
0.3 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.0 |
0.1 |
GO:1902430 |
negative regulation of beta-amyloid formation(GO:1902430) |
| 0.0 |
0.1 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.0 |
0.7 |
GO:0051973 |
positive regulation of telomerase activity(GO:0051973) |
| 0.0 |
0.1 |
GO:0050975 |
sensory perception of touch(GO:0050975) |
| 0.0 |
0.1 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.0 |
0.1 |
GO:0034433 |
steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
| 0.0 |
0.3 |
GO:0007569 |
cell aging(GO:0007569) |
| 0.0 |
0.3 |
GO:1901798 |
positive regulation of signal transduction by p53 class mediator(GO:1901798) |
| 0.0 |
0.1 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.0 |
0.1 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.0 |
0.2 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.0 |
0.1 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.0 |
0.1 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.0 |
0.2 |
GO:0002192 |
IRES-dependent translational initiation(GO:0002192) |
| 0.0 |
0.1 |
GO:0015870 |
acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
| 0.0 |
0.1 |
GO:0042726 |
flavin-containing compound metabolic process(GO:0042726) |
| 0.0 |
0.3 |
GO:0060688 |
regulation of morphogenesis of a branching structure(GO:0060688) |
| 0.0 |
0.1 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.0 |
0.0 |
GO:0042097 |
interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
| 0.0 |
0.1 |
GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
| 0.0 |
0.2 |
GO:0032801 |
receptor catabolic process(GO:0032801) |
| 0.0 |
0.1 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.0 |
0.0 |
GO:0001787 |
natural killer cell proliferation(GO:0001787) |
| 0.0 |
0.2 |
GO:1903975 |
regulation of glial cell migration(GO:1903975) |
| 0.0 |
0.1 |
GO:0061092 |
regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.0 |
0.1 |
GO:0044253 |
positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
| 0.0 |
0.3 |
GO:0015908 |
fatty acid transport(GO:0015908) |
| 0.0 |
0.5 |
GO:0031572 |
G2 DNA damage checkpoint(GO:0031572) |
| 0.0 |
0.0 |
GO:0034088 |
maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.0 |
0.0 |
GO:0071442 |
positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.0 |
0.0 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.0 |
0.1 |
GO:0036265 |
RNA (guanine-N7)-methylation(GO:0036265) |
| 0.0 |
0.1 |
GO:0000076 |
DNA replication checkpoint(GO:0000076) |
| 0.0 |
0.0 |
GO:0006206 |
pyrimidine nucleobase metabolic process(GO:0006206) |
| 0.0 |
0.1 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.0 |
0.1 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.0 |
0.2 |
GO:0051561 |
positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 0.0 |
0.3 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.0 |
0.0 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.0 |
0.1 |
GO:0006497 |
protein lipidation(GO:0006497) lipoprotein biosynthetic process(GO:0042158) |
| 0.0 |
0.1 |
GO:0031509 |
telomeric heterochromatin assembly(GO:0031509) regulation of chromosome condensation(GO:0060623) negative regulation of chromosome condensation(GO:1902340) |
| 0.0 |
0.2 |
GO:0006401 |
RNA catabolic process(GO:0006401) |
| 0.0 |
0.2 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
| 0.0 |
0.2 |
GO:0010640 |
regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
| 0.0 |
0.1 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.0 |
0.1 |
GO:0070307 |
lens fiber cell development(GO:0070307) |
| 0.0 |
0.0 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.0 |
0.0 |
GO:0070305 |
response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 0.0 |
0.0 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.0 |
0.0 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.0 |
0.8 |
GO:0051592 |
response to calcium ion(GO:0051592) |
| 0.0 |
0.1 |
GO:0043921 |
modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
| 0.0 |
0.4 |
GO:0007405 |
neuroblast proliferation(GO:0007405) |
| 0.0 |
0.2 |
GO:0001709 |
cell fate determination(GO:0001709) |
| 0.0 |
0.2 |
GO:0006656 |
phosphatidylcholine biosynthetic process(GO:0006656) |
| 0.0 |
0.1 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 0.0 |
0.6 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.0 |
0.2 |
GO:0010592 |
positive regulation of lamellipodium assembly(GO:0010592) |
| 0.0 |
0.1 |
GO:0000393 |
spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.0 |
0.1 |
GO:0036120 |
response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.0 |
0.1 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.0 |
1.4 |
GO:0007601 |
visual perception(GO:0007601) |
| 0.0 |
0.4 |
GO:1902750 |
negative regulation of cell cycle G2/M phase transition(GO:1902750) |
| 0.0 |
0.1 |
GO:0071638 |
negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
| 0.0 |
0.1 |
GO:0043551 |
regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
| 0.0 |
0.0 |
GO:0002716 |
negative regulation of leukocyte mediated cytotoxicity(GO:0001911) negative regulation of natural killer cell mediated immunity(GO:0002716) negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
| 0.0 |
0.0 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.0 |
0.1 |
GO:0043101 |
purine-containing compound salvage(GO:0043101) |
| 0.0 |
0.1 |
GO:0060018 |
astrocyte fate commitment(GO:0060018) |
| 0.0 |
0.2 |
GO:0008299 |
isoprenoid biosynthetic process(GO:0008299) |
| 0.0 |
0.2 |
GO:0031125 |
rRNA 3'-end processing(GO:0031125) |
| 0.0 |
0.8 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.0 |
0.5 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
| 0.0 |
0.7 |
GO:0048013 |
ephrin receptor signaling pathway(GO:0048013) |
| 0.0 |
0.5 |
GO:0048678 |
response to axon injury(GO:0048678) |
| 0.0 |
0.1 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.0 |
0.1 |
GO:0043486 |
histone exchange(GO:0043486) |
| 0.0 |
0.1 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.0 |
0.4 |
GO:0005978 |
glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.0 |
0.1 |
GO:1904030 |
negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.0 |
0.2 |
GO:0031111 |
negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
| 0.0 |
0.1 |
GO:1901660 |
calcium ion export(GO:1901660) |
| 0.0 |
0.1 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.0 |
0.1 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.0 |
0.1 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 0.0 |
0.0 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.0 |
0.0 |
GO:1901030 |
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
| 0.0 |
0.1 |
GO:0019377 |
glycolipid catabolic process(GO:0019377) |
| 0.0 |
0.1 |
GO:0033262 |
regulation of nuclear cell cycle DNA replication(GO:0033262) |
| 0.0 |
0.1 |
GO:0050715 |
positive regulation of cytokine secretion(GO:0050715) |
| 0.0 |
0.0 |
GO:0032066 |
nucleolus to nucleoplasm transport(GO:0032066) |
| 0.0 |
0.3 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.0 |
0.1 |
GO:0035902 |
response to immobilization stress(GO:0035902) |
| 0.0 |
0.1 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.0 |
0.0 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.0 |
0.1 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.0 |
0.1 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.0 |
0.1 |
GO:1990564 |
protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.0 |
0.1 |
GO:0010814 |
neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.0 |
0.1 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.0 |
0.1 |
GO:0048311 |
mitochondrion distribution(GO:0048311) |
| 0.0 |
0.1 |
GO:0019395 |
fatty acid oxidation(GO:0019395) |
| 0.0 |
0.1 |
GO:0036123 |
histone H3-K9 dimethylation(GO:0036123) |
| 0.0 |
0.1 |
GO:0036451 |
cap mRNA methylation(GO:0036451) |
| 0.0 |
0.2 |
GO:0071230 |
cellular response to amino acid stimulus(GO:0071230) |
| 0.0 |
0.2 |
GO:0006000 |
fructose metabolic process(GO:0006000) |
| 0.0 |
0.2 |
GO:0001964 |
startle response(GO:0001964) |
| 0.0 |
0.2 |
GO:0034340 |
response to type I interferon(GO:0034340) |
| 0.0 |
0.2 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.0 |
0.0 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.0 |
0.1 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 0.0 |
0.1 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.0 |
0.1 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.0 |
0.0 |
GO:0061087 |
positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.0 |
0.1 |
GO:0016558 |
protein import into peroxisome matrix(GO:0016558) |
| 0.0 |
0.1 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 0.0 |
0.1 |
GO:0035272 |
exocrine system development(GO:0035272) |
| 0.0 |
0.3 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.0 |
0.2 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.0 |
0.0 |
GO:0038033 |
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
| 0.0 |
0.2 |
GO:0000288 |
nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
| 0.0 |
0.3 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.0 |
0.0 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.0 |
0.5 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.0 |
0.0 |
GO:0050812 |
regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 0.0 |
0.1 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.0 |
0.1 |
GO:0009583 |
detection of light stimulus(GO:0009583) |
| 0.0 |
0.0 |
GO:0032776 |
DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
| 0.0 |
0.1 |
GO:0021555 |
midbrain-hindbrain boundary morphogenesis(GO:0021555) initiation of neural tube closure(GO:0021993) |
| 0.0 |
0.0 |
GO:0032695 |
negative regulation of interleukin-12 production(GO:0032695) |
| 0.0 |
0.1 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.0 |
0.1 |
GO:0048147 |
negative regulation of fibroblast proliferation(GO:0048147) |
| 0.0 |
0.3 |
GO:0043044 |
ATP-dependent chromatin remodeling(GO:0043044) |
| 0.0 |
0.5 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.0 |
0.4 |
GO:0000462 |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.0 |
0.1 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.0 |
0.0 |
GO:0010730 |
negative regulation of hydrogen peroxide metabolic process(GO:0010727) regulation of hydrogen peroxide biosynthetic process(GO:0010728) negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.0 |
0.0 |
GO:0045448 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.0 |
0.0 |
GO:0002756 |
MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
| 0.0 |
0.0 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.0 |
0.0 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.0 |
0.1 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.0 |
0.0 |
GO:0000429 |
carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) carbon catabolite regulation of transcription(GO:0045990) carbon catabolite activation of transcription(GO:0045991) |
| 0.0 |
0.0 |
GO:0042178 |
xenobiotic catabolic process(GO:0042178) |
| 0.0 |
0.1 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.0 |
0.1 |
GO:0060914 |
heart formation(GO:0060914) |
| 0.0 |
0.0 |
GO:0002082 |
regulation of oxidative phosphorylation(GO:0002082) |
| 0.0 |
0.1 |
GO:0071320 |
cellular response to cAMP(GO:0071320) |
| 0.0 |
0.1 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.0 |
0.1 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.0 |
0.0 |
GO:1902396 |
vesicle transport along actin filament(GO:0030050) protein localization to bicellular tight junction(GO:1902396) |
| 0.0 |
0.0 |
GO:1901843 |
positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 0.0 |
0.1 |
GO:1904321 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.0 |
0.4 |
GO:0022904 |
respiratory electron transport chain(GO:0022904) |
| 0.0 |
0.1 |
GO:0033260 |
nuclear DNA replication(GO:0033260) |
| 0.0 |
0.2 |
GO:0007080 |
mitotic metaphase plate congression(GO:0007080) |
| 0.0 |
0.0 |
GO:0043652 |
engulfment of apoptotic cell(GO:0043652) |
| 0.0 |
0.0 |
GO:0072531 |
pyrimidine-containing compound transmembrane transport(GO:0072531) nucleotide transmembrane transport(GO:1901679) |
| 0.0 |
0.2 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
| 0.0 |
0.1 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.0 |
0.0 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.0 |
0.0 |
GO:0097286 |
iron ion import(GO:0097286) |
| 0.0 |
0.0 |
GO:0019614 |
catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
| 0.0 |
0.1 |
GO:2001275 |
positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
| 0.0 |
0.0 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.0 |
0.0 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.0 |
0.0 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.0 |
0.0 |
GO:0007182 |
common-partner SMAD protein phosphorylation(GO:0007182) |
| 0.0 |
0.1 |
GO:1901722 |
regulation of cell proliferation involved in kidney development(GO:1901722) positive regulation of cell proliferation involved in kidney development(GO:1901724) |
| 0.0 |
0.5 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.0 |
0.1 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.0 |
0.0 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.0 |
0.0 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.0 |
0.1 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
